1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Vital Signs The Analyst%s Perspective - November 2015 Issue 

Vital Signs The Analyst%s Perspective - November 2015 Issue 

  • January 2016
  • -
  • Frost & Sullivan
  • -
  • 7 pages

This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.

Table Of Contents

Vital Signs The Analyst%s Perspective - November 2015 Issue 
MDxHealth Launches SelectMDx Liquid Biopsy Test in Europe 2
FDA Approves New Treatment for Non-small Cell Lung Cancer with EGFR Mutations 3
US Drug Benefit Managers Clamp Down on Specialty Pharmacies 4
Sequencing Service Provider Stops Planned Instrument Launch, Redirects Strategy 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Next Generation Sequencing (NGS) Global market - Forecast to 2022

Next Generation Sequencing (NGS) Global market - Forecast to 2022

  • $ 4950
  • Industry report
  • November 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the ...

Next Generation Sequencing - Global Market Outlook (2016-2022)

Next Generation Sequencing - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • January 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to ...

Global In-Vitro Toxicology Testing Market

Global In-Vitro Toxicology Testing Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of ...

Global Precision Medicine Market

December 2016 $ 4250

Download Unlimited Documents from Trusted Public Sources

Genome Sequencing Industry in the US

  • February 2017
    93 pages
  • Genome Sequenci...  

    Crop Production  

  • United States  

View report >

Genomics Industry

  • January 2017
    9 pages
  • Genomics  

    Genetic  

    Genomics  

  • Africa  

    United States  

    Europe  

View report >

Cytogenetic Statistics

  • January 2017
    37 pages
  • Cytogenetic  

View report >

Related Market Segments :

Genome Sequencing
Genomics

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.